Department of Rare Skeletal Disorders, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Orphanet J Rare Dis. 2024 Feb 13;19(1):63. doi: 10.1186/s13023-023-03006-8.
Multiple osteochondromas is genetic disorder characterized by the formation of multiple benign cartilage-capped bone tumors, named osteochondromas, during skeletal development. The most feared complication is the secondary peripheral chondrosarcoma, a malignant cartilaginous neoplasm that arises from the chondroid cap of pre-existent osteochondromas. We conducted a retrospective cohort study on patients diagnosed and followed up from 1960 to 2019 to describe the clinical and pathological features of individuals affected by peripheral chondrosarcoma in multiple osteochondromas, to evaluate follow up information and individual outcome and to compare the results with literature. Data, including age, gender, site, histological grade, cartilage cap thickness, surgical treatments, surgical margins, genotype mutational status as well as treatment details were captured from the hospital electronic health records and from Registry of Multiple Osteochondromas. In addition, a complete histological review of all hematoxylin and eosin (H&E)-stained sections has been performed by expert pathologists.
One hundred five of the screened cases were included in the present study. The age at diagnosis of SPC ranges from 13 to 63, with median age at diagnosis of 34 years. The site most frequently affected by malignant degeneration was the pelvis (46 patients, 44%) with higher incidence in male patients (32 males vs.14 females). The second one was lower limbs (including femur, fibula, or tibia), identified in 35 patients. Histological information - available for 103 patients - showed: 59 patients with grade 1; 40 patients had a grade 2 and 4 patients had a grade 3. The most common surgical treatment was the complete resection, followed by debulking, amputation and partial resection. Most of cases did not have recurrence of the disease. Outcome in disease-free survival highlights that a worse course of the disease was associated with histological grade 2 or 3, and partial resection surgery. In most of analyzed cases (94%) a pathogenic variant was identified.
In conclusion, the present study gives an overview of the secondary peripheral chondrosarcomas, confirming that this disease represents an impacting complication for multiple osteochondromas patients and suggests that malignant transformation can occur also in younger patient, in a not irrelevant number of cases.
多发性骨软骨瘤是一种遗传性疾病,其特征是在骨骼发育过程中形成多个良性软骨帽骨肿瘤,称为骨软骨瘤。最可怕的并发症是继发的外周软骨肉瘤,这是一种恶性软骨性肿瘤,起源于先前存在的骨软骨瘤的软骨帽。我们对 1960 年至 2019 年期间诊断和随访的患者进行了回顾性队列研究,以描述多发性骨软骨瘤中继发外周软骨肉瘤患者的临床和病理特征,评估随访信息和个体预后,并将结果与文献进行比较。数据包括年龄、性别、部位、组织学分级、软骨帽厚度、手术治疗、手术切缘、基因突变状态以及治疗细节,均从医院电子健康记录和多发性骨软骨瘤登记处获取。此外,由专家病理学家对所有苏木精和伊红(H&E)染色切片进行了完整的组织学复查。
筛选出的 105 例病例纳入本研究。SPC 的诊断年龄为 13 至 63 岁,中位诊断年龄为 34 岁。最常发生恶性转化的部位是骨盆(46 例,44%),男性发病率高于女性(32 例男性比 14 例女性)。其次是下肢(包括股骨、腓骨或胫骨),共 35 例。可获得组织学信息的 103 例患者中:59 例为 1 级;40 例为 2 级,4 例为 3 级。最常见的手术治疗是完全切除,其次是减瘤术、截肢术和部分切除术。大多数患者无疾病复发。无病生存结局突出显示,疾病严重程度与组织学分级 2 级或 3 级以及部分切除术相关。在大多数分析病例中(94%)发现了致病性变异。
总之,本研究概述了继发外周软骨肉瘤,证实该病是多发性骨软骨瘤患者的一个严重并发症,并提示恶性转化也可能发生在年轻患者中,且在一定数量的病例中发生。